Related references
Note: Only part of the references are listed.
Letter
Anesthesiology
Naama Lieberman et al.
BRITISH JOURNAL OF ANAESTHESIA
(2022)
Article
Anesthesiology
James C. Glasbey et al.
BRITISH JOURNAL OF ANAESTHESIA
(2022)
Article
Gastroenterology & Hepatology
Michel Adamina et al.
Summary: This study compared the resectability of colorectal cancer patients undergoing delayed surgery versus non-delayed surgery. The results suggest that surgical delay does not compromise resectability, but may affect long-term survival.
COLORECTAL DISEASE
(2022)
Article
Gastroenterology & Hepatology
Siobhan C. McKay et al.
Summary: This study aimed to determine the risk of SARS-CoV-2 infection for elective HPB cancer surgery and found that patients infected with SARS-CoV-2 had a higher risk of perioperative mortality and complications compared to those without the infection. This association persisted even after adjusting for age, sex, and comorbidities. SARS-CoV-2 infection was also associated with postoperative bleeding and pancreatic fistula.
Article
Oncology
Mitsuo Terada et al.
Summary: This observational study investigated the efficacy and impact of SARS-CoV-2 vaccination against variants on treatment among breast cancer patients in Japan, revealing varying degrees of decreased neutralizing antibody titers against the virus among patients receiving chemotherapy or CDK4/6 inhibitors.
BREAST CANCER RESEARCH AND TREATMENT
(2022)
Review
Health Care Sciences & Services
P. Ranganathan et al.
Summary: The COVID-19 pandemic has presented challenges to cancer research, but researchers have adapted by making protocol amendments, utilizing digital technologies, and conducting "virtual" clinical trials. These adaptations have proven to be safe and feasible, while also bringing benefits such as increased patient participation, reduced burden on patients, and reduced resources needed for trials. The lessons learned from the pandemic and the innovative measures taken by researchers are likely to improve the efficiency of clinical research even after the pandemic.
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE
(2022)
Article
Medicine, General & Internal
Steven Habbous et al.
Summary: This study compared the use and short-term outcomes of neoadjuvant-intent vs adjuvant systemic treatment (ST) in breast cancer patients during the COVID-19 era and the pre-COVID-19 era. It found that patients were more likely to receive neoadjuvant ST in the COVID-19 era, but there was limited evidence of substantial impact on short-term outcomes.
Article
Medicine, General & Internal
Kalyan K. Mukherjee et al.
Summary: This study suggests that there is no comorbidity between cancer and COVID-19 patients in the Indian population, with only a small percentage of patients testing positive for COVID-19.
ANNALS OF MEDICINE AND SURGERY
(2022)
Article
Medicine, General & Internal
Kalyan K. Mukherjee et al.
Summary: The study found that only 3.4% of cancer patients in India tested positive for COVID-19, and cancer is not a common comorbid condition for COVID-19 patients in the population studied. There was a predominance of female patients, with most infections occurring in the 45-59 age group.
ANNALS OF MEDICINE AND SURGERY
(2022)
Article
Gastroenterology & Hepatology
Aneel Bhangu
Summary: This study aimed to describe the impact of SARS-CoV-2 on mortality and surgical practice after colorectal cancer resection during the initial phases of the pandemic. The results showed a significant association between postoperative SARS-CoV-2 infection and anastomotic leaks with mortality, emphasizing the need for surgeons to reduce these risks during current and future COVID-19 waves.
COLORECTAL DISEASE
(2021)
Review
Health Care Sciences & Services
Peter Moriarty et al.
Summary: The COVID-19 pandemic was officially declared by the World Health Organization in March 2020, with London emerging as a major hotspot in the United Kingdom. A cancer COVID-19-free cold hub was established through collaboration between the National Health Service and independent institutions to provide safe surgery for surgical oncology patients. Key strategies for restructuring the cancer service included establishing an accessible referral pathway, creating cold hub hospitals, developing infection control protocols and preoperative testing, rapid service reorganization based on feedback, clear communication and leadership. This approach proved successful in minimizing COVID-19 transmission, morbidity, and mortality, demonstrating a viable system that can be implemented in other healthcare settings.
JOURNAL OF PATIENT SAFETY
(2021)
Article
Anesthesiology
D. Nepogodiev et al.
Summary: The study suggests that surgery should be delayed for at least 7 weeks following SARS-CoV-2 infection, with patients experiencing ongoing symptoms >= 7 weeks from diagnosis potentially benefitting from further delay.
Article
Oncology
James C. Glasbey et al.
Summary: During the COVID-19 pandemic, lockdown measures have led to a portion of cancer patients not being able to receive planned surgery. In regions with full lockdowns, one in seven patients did not undergo surgery and experienced longer waiting times. Although short-term oncological outcomes were not greatly affected, delayed surgeries might result in long-term reduction in survival.
Article
Surgery
K. A. McLean et al.
Summary: This study compared the impact of pulmonary complications on postoperative mortality before and during the COVID-19 pandemic, finding that although lower-risk patients were selected for surgery during the pandemic, the mortality rate still significantly increased, with over half of the excess deaths being attributed to SARS-CoV-2 infection.
BRITISH JOURNAL OF SURGERY
(2021)
Article
Surgery
Dmitri Nepogodiev et al.
Summary: Preoperative SARS-CoV-2 vaccination can support safer elective surgery. The number needed to vaccinate (NNV) to prevent COVID-19-related deaths is more favorable in surgical patients compared to the general population. Prioritizing preoperative vaccination of patients needing elective surgery globally could prevent additional COVID-19-related deaths in 1 year.
BRITISH JOURNAL OF SURGERY
(2021)
Letter
Medicine, General & Internal
Maximos Frountzas et al.
BALKAN MEDICAL JOURNAL
(2021)
Review
Oncology
Konstantinos Apostolou et al.
Summary: During the COVID-19 outbreak, performing surgical procedures has become extremely challenging, with the most common criteria for prioritizing surgical treatment being stage, tumor biology, presence of tumor-related symptoms, risk of unresectability, and time interval from neoadjuvant therapy.
JOURNAL OF GASTROINTESTINAL CANCER
(2021)
Article
Oncology
Timothy M. Pawlik et al.
ANNALS OF SURGICAL ONCOLOGY
(2020)
Review
Oncology
Konstantinos Tsamakis et al.
Article
Medicine, General & Internal
Dimitrios Moris et al.
Article
Medicine, Research & Experimental
Dimitrios Moris et al.
